These tools set cookies that store anonymised information about how you got to the site, and how you interact with the site.

It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...

In the talks both ourselves and NHS England continued to offer as much flexibility as possible, but despite the intervention of Secretary of State for Health Wes Streeting, the companies did not put ...

Associate professor and director of the Medical Technology Research Group, London School of Economics and Political Science (LSE) The rapidly evolving healthcare landscape demands leaders who can ...

These sections briefly explain why the committee made the recommendations and how they might affect practice. As this guideline applies to England and Scotland, the perspective was for both England ...

We will update the guideline on asthma.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

To find BTS, NICE or SIGN guidance on related topics, including guidance in development, see the BTS guidelines, the NICE topic page on asthma and the SIGN guidelines. For full details of the evidence ...

See recommendations on pharmacological management in people aged 12 and over and the summary of pharmacological management in people aged 12 years and over in the BTS, NICE and SIGN guideline on ...

See recommendations on initial clinical assessment in the BTS, NICE and SIGN guideline on asthma. See also, the tables on alternative diagnoses in wheezy children and alternative diagnoses in adults ...